Non-invasive health diagnostics are on the rise, and fingerprint testing technology is at the forefront. This article explores the history and ongoing development of fingerprint sweat analysis and its potential to transform how we monitor and manage various health conditions. It further discusses possible applications such as detecting and managing conditions like epilepsy, stress, and…
NEW YORK, April 11, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, with the grant of a new European patent with unitary effect for…
NEW YORK, February 28, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its partnership with Cliantha Research, a full-service Clinical Research Organization (CRO), to perform a pharmacokinetic (PK) study forming part of the Company’s FDA 510(k) clinical study plan….
NEW YORK, February 16, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that on February 13, 2024, it received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance…
NEW YORK, February 09, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for fiscal second quarter and six months ended December 31, 2023, and provided a business update. “We are very pleased with our fiscal Q2…
NEW YORK, February 02, 2024 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary unaudited revenue results for fiscal Second Quarter and six months ended December 31, 2023. The Company expects approximate unaudited revenue of $1.56 million for the six months ended December…
Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint drug testing
Intelligent Fingerprinting to be used for in-house drug testing, enabling full testing control to support new James Jones drug and
Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing
Intelligent Bio Solutions Inc. today announced that Robinson Brothers, one of the UK’s largest independent chemical manufacturers, is now using
Intelligent Bio Solutions Inc. today announced that it has received National Association of Testing Authorities (NATA) accreditation for its Intelligent
Australia, known for its thriving economy and competitive job market, is experiencing an alarming increase in substance abuse among white-collar
December 5, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that leading pan-European ferry and logistics company, P&O Ferries, is now using the revolutionary portable Intelligent Fingerprinting Drug Screening System to support its drug and alcohol testing policy. P&O…
Since 2001, Titan has secured its spot as Australasia’s leading specialist material handling company, providing state-of-the-art lifting equipment and labor
Intelligent Bio Solutions Inc. today announced that it will present at the Emerging Growth Conference on December 7, 2023. The
